Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.

Identifieur interne : 000193 ( France/Analysis ); précédent : 000192; suivant : 000194

Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.

Auteurs : Caroline Compain [France] ; Karim Sacre ; Xavier Puéchal ; Isabelle Klein ; Denis Vital-Durand ; Jean-Luc Houeto ; Thomas De Broucker ; Didier Raoult ; Thomas Papo

Source :

RBID : pubmed:24145700

Descripteurs français

English descriptors

Abstract

Whipple disease (WD) is a rare multisystemic infection with a protean clinical presentation. The central nervous system (CNS) is involved in 3 situations: CNS involvement in classic WD, CNS relapse in previously treated WD, and isolated CNS infection. We retrospectively analyzed clinical features, diagnostic workup, brain imaging, cerebrospinal fluid (CSF) study, treatment, and follow-up data in 18 patients with WD and CNS infection. Ten men and 8 women were included with a median age at diagnosis of 47 years (range, 30-56 yr). The median follow-up duration was 6 years (range, 1-19 yr). As categorized in the 3 subgroups, 11 patients had classic WD with CNS involvement, 4 had an isolated CNS infection, and 3 had a neurologic relapse of previously treated WD. CNS involvement occurred during prolonged trimethoprim-sulfamethoxazole (TMP-SMX) treatment in 1 patient with classic WD. The neurologic symptoms were various and always intermingled, as follows: confusion or coma (17%) related to meningo-encephalitis or status epilepticus; delirium (17%); cognitive impairment (61%) including memory loss and attention defects or typical frontal lobe syndrome; hypersomnia (17%); abnormal movements (myoclonus, choreiform movements, oculomasticatory myorhythmia) (39%); cerebellar ataxia (11%); upper motor neuron (44%) or extrapyramidal symptoms (33%); and ophthalmoplegia (17%) in conjunction or not with progressive supranuclear palsy. No specific pattern was correlated with any subgroup. Brain magnetic resonance imaging (MRI) revealed a unique focal lesion (35%), mostly as a tumorlike brain lesion, or multifocal lesions (23%) involving the medial temporal lobe, midbrain, hypothalamus, and thalamus. Periventricular diffuse leukopathy (6%), diffuse cortical atrophy (18%), and pachymeningitis (12%) were observed. The spinal cord was involved in 2 cases. MRI showed ischemic sequelae at diagnosis or during follow-up in 4 patients. Brain MRI was normal despite neurologic symptoms in 3 cases. CSF cytology was normal in 62% of patients, whereas Tropheryma whipplei polymerase chain reaction (PCR) analysis was positive in 92% of cases with tested CSF. Periodic acid-Schiff (PAS)-positive cells were identified in cerebral biopsies of 4 patients. All patients were treated with antimicrobial therapy for a mean duration of 2 years (range, 1-7 yr) with either oral monotherapy (TMP-SMX, doxycycline, third-generation cephalosporins) or a combination of antibiotics that sometimes followed parenteral treatment with beta-lactams and aminoglycosides. Eight patients also received hydroxychloroquine. At the end of follow-up, the clinical outcome was favorable in 14 patients (78%), with mild to moderate sequelae in 9. Thirteen patients (72%) had stopped treatment for an average time of 4 years (range, 0.7-14 yr). Four patients had clinical worsening despite antimicrobial therapy; 2 of those died following diffuse encephalitis (n = 1) and lung infection (n = 1). In conclusion, the neurologic manifestations of WD are diverse and may mimic almost any neurologic condition. Brain involvement may occur during or after TMP-SMX treatment. CSF T. whipplei PCR analysis is a major tool for diagnosis and may be positive in the absence of meningitis. Immune reconstitution syndrome may occur in the early months of treatment. Late prognosis may be better than previously reported, as a consequence of earlier diagnosis and a better use of antimicrobial therapy, including hydroxychloroquine and doxycycline combination.

DOI: 10.1097/MD.0000000000000010
PubMed: 24145700


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24145700

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.</title>
<author>
<name sortKey="Compain, Caroline" sort="Compain, Caroline" uniqKey="Compain C" first="Caroline" last="Compain">Caroline Compain</name>
<affiliation wicri:level="3">
<nlm:affiliation>From the Service de Médecine Interne (CC, KS, TP) and Service de Radiologie (IK), Université Paris Diderot, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris; INSERM U699, (KS) Université Paris Diderot, Paris; Centre de Référence National sur les Vascularites Systémiques (XP), Université Paris-Descartes, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris; Service de Médecine Interne (DV-D), Université Lyon-Sud, Lyon; Service de Neurologie (J-LH), Université Poitiers, Poitiers; Service de Neurologie (TDB), Hôpital de Saint-Denis, Saint Denis; Aix Marseille Université (DR), URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>From the Service de Médecine Interne (CC, KS, TP) and Service de Radiologie (IK), Université Paris Diderot, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris; INSERM U699, (KS) Université Paris Diderot, Paris; Centre de Référence National sur les Vascularites Systémiques (XP), Université Paris-Descartes, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris; Service de Médecine Interne (DV-D), Université Lyon-Sud, Lyon; Service de Neurologie (J-LH), Université Poitiers, Poitiers; Service de Neurologie (TDB), Hôpital de Saint-Denis, Saint Denis; Aix Marseille Université (DR), URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille</wicri:regionArea>
<placeName>
<region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sacre, Karim" sort="Sacre, Karim" uniqKey="Sacre K" first="Karim" last="Sacre">Karim Sacre</name>
</author>
<author>
<name sortKey="Puechal, Xavier" sort="Puechal, Xavier" uniqKey="Puechal X" first="Xavier" last="Puéchal">Xavier Puéchal</name>
</author>
<author>
<name sortKey="Klein, Isabelle" sort="Klein, Isabelle" uniqKey="Klein I" first="Isabelle" last="Klein">Isabelle Klein</name>
</author>
<author>
<name sortKey="Vital Durand, Denis" sort="Vital Durand, Denis" uniqKey="Vital Durand D" first="Denis" last="Vital-Durand">Denis Vital-Durand</name>
</author>
<author>
<name sortKey="Houeto, Jean Luc" sort="Houeto, Jean Luc" uniqKey="Houeto J" first="Jean-Luc" last="Houeto">Jean-Luc Houeto</name>
</author>
<author>
<name sortKey="De Broucker, Thomas" sort="De Broucker, Thomas" uniqKey="De Broucker T" first="Thomas" last="De Broucker">Thomas De Broucker</name>
</author>
<author>
<name sortKey="Raoult, Didier" sort="Raoult, Didier" uniqKey="Raoult D" first="Didier" last="Raoult">Didier Raoult</name>
</author>
<author>
<name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24145700</idno>
<idno type="pmid">24145700</idno>
<idno type="doi">10.1097/MD.0000000000000010</idno>
<idno type="wicri:Area/PubMed/Corpus">000319</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000319</idno>
<idno type="wicri:Area/PubMed/Curation">000319</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000319</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000332</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000332</idno>
<idno type="wicri:Area/Ncbi/Merge">000221</idno>
<idno type="wicri:Area/Ncbi/Curation">000221</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000221</idno>
<idno type="wicri:Area/Main/Merge">001121</idno>
<idno type="wicri:Area/Main/Curation">001120</idno>
<idno type="wicri:Area/Main/Exploration">001120</idno>
<idno type="wicri:Area/France/Extraction">000193</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.</title>
<author>
<name sortKey="Compain, Caroline" sort="Compain, Caroline" uniqKey="Compain C" first="Caroline" last="Compain">Caroline Compain</name>
<affiliation wicri:level="3">
<nlm:affiliation>From the Service de Médecine Interne (CC, KS, TP) and Service de Radiologie (IK), Université Paris Diderot, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris; INSERM U699, (KS) Université Paris Diderot, Paris; Centre de Référence National sur les Vascularites Systémiques (XP), Université Paris-Descartes, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris; Service de Médecine Interne (DV-D), Université Lyon-Sud, Lyon; Service de Neurologie (J-LH), Université Poitiers, Poitiers; Service de Neurologie (TDB), Hôpital de Saint-Denis, Saint Denis; Aix Marseille Université (DR), URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>From the Service de Médecine Interne (CC, KS, TP) and Service de Radiologie (IK), Université Paris Diderot, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris; INSERM U699, (KS) Université Paris Diderot, Paris; Centre de Référence National sur les Vascularites Systémiques (XP), Université Paris-Descartes, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris; Service de Médecine Interne (DV-D), Université Lyon-Sud, Lyon; Service de Neurologie (J-LH), Université Poitiers, Poitiers; Service de Neurologie (TDB), Hôpital de Saint-Denis, Saint Denis; Aix Marseille Université (DR), URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille</wicri:regionArea>
<placeName>
<region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sacre, Karim" sort="Sacre, Karim" uniqKey="Sacre K" first="Karim" last="Sacre">Karim Sacre</name>
</author>
<author>
<name sortKey="Puechal, Xavier" sort="Puechal, Xavier" uniqKey="Puechal X" first="Xavier" last="Puéchal">Xavier Puéchal</name>
</author>
<author>
<name sortKey="Klein, Isabelle" sort="Klein, Isabelle" uniqKey="Klein I" first="Isabelle" last="Klein">Isabelle Klein</name>
</author>
<author>
<name sortKey="Vital Durand, Denis" sort="Vital Durand, Denis" uniqKey="Vital Durand D" first="Denis" last="Vital-Durand">Denis Vital-Durand</name>
</author>
<author>
<name sortKey="Houeto, Jean Luc" sort="Houeto, Jean Luc" uniqKey="Houeto J" first="Jean-Luc" last="Houeto">Jean-Luc Houeto</name>
</author>
<author>
<name sortKey="De Broucker, Thomas" sort="De Broucker, Thomas" uniqKey="De Broucker T" first="Thomas" last="De Broucker">Thomas De Broucker</name>
</author>
<author>
<name sortKey="Raoult, Didier" sort="Raoult, Didier" uniqKey="Raoult D" first="Didier" last="Raoult">Didier Raoult</name>
</author>
<author>
<name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
</author>
</analytic>
<series>
<title level="j">Medicine</title>
<idno type="eISSN">1536-5964</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Anti-Infective Agents (therapeutic use)</term>
<term>Central Nervous System Infections (cerebrospinal fluid)</term>
<term>Central Nervous System Infections (drug therapy)</term>
<term>Central Nervous System Infections (epidemiology)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Recurrence</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Tropheryma (drug effects)</term>
<term>Tropheryma (pathogenicity)</term>
<term>Whipple Disease (cerebrospinal fluid)</term>
<term>Whipple Disease (drug therapy)</term>
<term>Whipple Disease (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anti-infectieux (usage thérapeutique)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Imagerie par résonance magnétique</term>
<term>Infections du système nerveux central ()</term>
<term>Infections du système nerveux central (traitement médicamenteux)</term>
<term>Infections du système nerveux central (épidémiologie)</term>
<term>Maladie de Whipple ()</term>
<term>Maladie de Whipple (traitement médicamenteux)</term>
<term>Maladie de Whipple (épidémiologie)</term>
<term>Mâle</term>
<term>Récidive</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Tropheryma ()</term>
<term>Tropheryma (pathogénicité)</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Infective Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="cerebrospinal fluid" xml:lang="en">
<term>Central Nervous System Infections</term>
<term>Whipple Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Tropheryma</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Central Nervous System Infections</term>
<term>Whipple Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Central Nervous System Infections</term>
<term>Whipple Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Tropheryma</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Tropheryma</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections du système nerveux central</term>
<term>Maladie de Whipple</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anti-infectieux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Infections du système nerveux central</term>
<term>Maladie de Whipple</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Recurrence</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Imagerie par résonance magnétique</term>
<term>Infections du système nerveux central</term>
<term>Maladie de Whipple</term>
<term>Mâle</term>
<term>Récidive</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Tropheryma</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Whipple disease (WD) is a rare multisystemic infection with a protean clinical presentation. The central nervous system (CNS) is involved in 3 situations: CNS involvement in classic WD, CNS relapse in previously treated WD, and isolated CNS infection. We retrospectively analyzed clinical features, diagnostic workup, brain imaging, cerebrospinal fluid (CSF) study, treatment, and follow-up data in 18 patients with WD and CNS infection. Ten men and 8 women were included with a median age at diagnosis of 47 years (range, 30-56 yr). The median follow-up duration was 6 years (range, 1-19 yr). As categorized in the 3 subgroups, 11 patients had classic WD with CNS involvement, 4 had an isolated CNS infection, and 3 had a neurologic relapse of previously treated WD. CNS involvement occurred during prolonged trimethoprim-sulfamethoxazole (TMP-SMX) treatment in 1 patient with classic WD. The neurologic symptoms were various and always intermingled, as follows: confusion or coma (17%) related to meningo-encephalitis or status epilepticus; delirium (17%); cognitive impairment (61%) including memory loss and attention defects or typical frontal lobe syndrome; hypersomnia (17%); abnormal movements (myoclonus, choreiform movements, oculomasticatory myorhythmia) (39%); cerebellar ataxia (11%); upper motor neuron (44%) or extrapyramidal symptoms (33%); and ophthalmoplegia (17%) in conjunction or not with progressive supranuclear palsy. No specific pattern was correlated with any subgroup. Brain magnetic resonance imaging (MRI) revealed a unique focal lesion (35%), mostly as a tumorlike brain lesion, or multifocal lesions (23%) involving the medial temporal lobe, midbrain, hypothalamus, and thalamus. Periventricular diffuse leukopathy (6%), diffuse cortical atrophy (18%), and pachymeningitis (12%) were observed. The spinal cord was involved in 2 cases. MRI showed ischemic sequelae at diagnosis or during follow-up in 4 patients. Brain MRI was normal despite neurologic symptoms in 3 cases. CSF cytology was normal in 62% of patients, whereas Tropheryma whipplei polymerase chain reaction (PCR) analysis was positive in 92% of cases with tested CSF. Periodic acid-Schiff (PAS)-positive cells were identified in cerebral biopsies of 4 patients. All patients were treated with antimicrobial therapy for a mean duration of 2 years (range, 1-7 yr) with either oral monotherapy (TMP-SMX, doxycycline, third-generation cephalosporins) or a combination of antibiotics that sometimes followed parenteral treatment with beta-lactams and aminoglycosides. Eight patients also received hydroxychloroquine. At the end of follow-up, the clinical outcome was favorable in 14 patients (78%), with mild to moderate sequelae in 9. Thirteen patients (72%) had stopped treatment for an average time of 4 years (range, 0.7-14 yr). Four patients had clinical worsening despite antimicrobial therapy; 2 of those died following diffuse encephalitis (n = 1) and lung infection (n = 1). In conclusion, the neurologic manifestations of WD are diverse and may mimic almost any neurologic condition. Brain involvement may occur during or after TMP-SMX treatment. CSF T. whipplei PCR analysis is a major tool for diagnosis and may be positive in the absence of meningitis. Immune reconstitution syndrome may occur in the early months of treatment. Late prognosis may be better than previously reported, as a consequence of earlier diagnosis and a better use of antimicrobial therapy, including hydroxychloroquine and doxycycline combination.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Provence-Alpes-Côte d'Azur</li>
</region>
<settlement>
<li>Marseille</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="De Broucker, Thomas" sort="De Broucker, Thomas" uniqKey="De Broucker T" first="Thomas" last="De Broucker">Thomas De Broucker</name>
<name sortKey="Houeto, Jean Luc" sort="Houeto, Jean Luc" uniqKey="Houeto J" first="Jean-Luc" last="Houeto">Jean-Luc Houeto</name>
<name sortKey="Klein, Isabelle" sort="Klein, Isabelle" uniqKey="Klein I" first="Isabelle" last="Klein">Isabelle Klein</name>
<name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
<name sortKey="Puechal, Xavier" sort="Puechal, Xavier" uniqKey="Puechal X" first="Xavier" last="Puéchal">Xavier Puéchal</name>
<name sortKey="Raoult, Didier" sort="Raoult, Didier" uniqKey="Raoult D" first="Didier" last="Raoult">Didier Raoult</name>
<name sortKey="Sacre, Karim" sort="Sacre, Karim" uniqKey="Sacre K" first="Karim" last="Sacre">Karim Sacre</name>
<name sortKey="Vital Durand, Denis" sort="Vital Durand, Denis" uniqKey="Vital Durand D" first="Denis" last="Vital-Durand">Denis Vital-Durand</name>
</noCountry>
<country name="France">
<region name="Provence-Alpes-Côte d'Azur">
<name sortKey="Compain, Caroline" sort="Compain, Caroline" uniqKey="Compain C" first="Caroline" last="Compain">Caroline Compain</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000193 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000193 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:24145700
   |texte=   Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:24145700" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021